Haptoglobin levels, but not Hp1-Hp2 polymorphism, are associated with polycystic ovary syndrome

Autor: Márcia F. A. Teixeira, Fernando M. Reis, Luana B. Xavier, Karina Braga Gomes, Laura M. L. Carvalho, Kathryna Fontana Rodrigues, Ieda de Fátima Oliveira Silva, Daisy K. D. de Oliveira, Rita Carolina Figueiredo Duarte, Fernanda M.F. Campos, Cláudia N. Ferreira, Ana L. Candido
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
Adult
Proteomics
medicine.medical_specialty
endocrine system diseases
Adolescent
Inflammation
Oxidative phosphorylation
medicine.disease_cause
Pathogenesis
03 medical and health sciences
Young Adult
0302 clinical medicine
Internal medicine
Genetics
Medicine
Humans
Genetics (clinical)
030219 obstetrics & reproductive medicine
Polymorphism
Genetic

biology
Haptoglobins
business.industry
Haptoglobin
food and beverages
Obstetrics and Gynecology
General Medicine
Polycystic ovary
Human genetics
030104 developmental biology
Endocrinology
Reproductive Physiology and Disease
Cross-Sectional Studies
Reproductive Medicine
Case-Control Studies
Immunology
biology.protein
Female
Hemoglobin
medicine.symptom
Insulin Resistance
business
Oxidative stress
Biomarkers
Developmental Biology
Polycystic Ovary Syndrome
Popis: Proteomic studies suggest an association between haptoglobin (Hp) and polycystic ovary syndrome (PCOS). Hp is a classic inflammatory marker and binds to the intravascular hemoglobin, avoiding the oxidative damages that can be caused by free hemoglobin. Inflammation and oxidative stress are important in the pathogenesis of the PCOS, one of the most frequent metabolic diseases in women.To validate these proteomic studies, we developed a controlled cross-sectional study that aimed to evaluate the Hp levels and allelic and genotypic frequencies of Hp1-Hp2 polymorphism in Brazilian women with PCOS. We also investigated the correlation between Hp levels and several important parameters in PCOS as follows: body mass index (BMI), waist circumference (WC), fasting glucose, post-prandial glucose, homeostatic model assessment (HOMA), lipid accumulation product (LAP), C-reactive protein (CRP), and metabolization test of tetrazolium salts (MTTs-serum antioxidant capacity).Plasma Hp levels were higher in the PCOS group than in controls [8.20 (4.04) g/L; 7.98 (3.31) g/L; p = 0.018]. No significant difference was observed in the frequency of Hp1-Hp2 genotypes under additive, recessive, or dominant model of inheritance between the PCOS and the control groups. Plasma Hp levels did not differ according to the genotype. However, plasma Hp showed a negative correlation with MTT (r = - 0.383; p = 0.028), as well as a positive correlation with CRP (r = 0.361; p = 0.014) in the PCOS group.Hp1-Hp2 polymorphism is not associated with PCOS but plasma Hp could be a potential biomarker for PCOS and its complications.
Databáze: OpenAIRE